Your shopping cart is currently empty

Minodronic acid-d4 is a deuterated compound of Minodronic acid. Minodronic acid has a CAS number of 180064-38-4. Minodronic acid(YM-529) is a P2X2/3 receptor antagonist with anticancer activity, directly or indirectly inhibiting the proliferation of cancer cells and inducing apoptosis. Minodronic acid has been shown to inhibit the metastasis of various types of cancer cells.Minodronic-acid has been used in the study of osteoporosis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | 20 days | 20 days | |
| 5 mg | Inquiry | 20 days | 20 days |
| Description | Minodronic acid-d4 is a deuterated compound of Minodronic acid. Minodronic acid has a CAS number of 180064-38-4. Minodronic acid(YM-529) is a P2X2/3 receptor antagonist with anticancer activity, directly or indirectly inhibiting the proliferation of cancer cells and inducing apoptosis. Minodronic acid has been shown to inhibit the metastasis of various types of cancer cells.Minodronic-acid has been used in the study of osteoporosis. |
| Molecular Weight | 326.17 |
| Formula | C9H8D4N2O7P2 |
| Cas No. | 1807367-80-1 |
| Smiles | C(P(=O)(O)O)(P(=O)(O)O)(O)CC1N2C(=NC=1)C([2H])=C([2H])C([2H])=C2[2H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.